Key result
HDL subfractions offer no predictive advantage over total HDL-C for coronary disease.
Although a variety of methods have become available for the determination of high-density lipoprotein (HDL) subfractions in plasma, a review of published data from nine studies of coronary disease outcomes and 10 investigations of coronary artery disease severity do no suggest that measurement of HDL2-cholesterol (C) and HDL3-C offer any advantage in the prediction of coronary disease over the determination of total HDL-C alone. Apolipoprotein E is typically present in plasma as one of six isoforms, the six being encoded by three common alleles, epsilon 2, epsilon 3, and epsilon 4. The epsilon 3 allele is the most common, the epsilon 4 allele has been reported to be associated with higher cholesterol concentrations, and the epsilon 2 and epsilon 4 alleles are both associated with higher triglyceride concentrations. Clinical and arteriographic studies of coronary disease suggest that vascular disease risk is increased among persons with the epsilon 4 allele.
No takes yet. Share an insight, caveat, or question.
P W Wilson (1995) conducted a review in Coronary artery disease. HDL2-C and HDL3-C subfractions and apolipoprotein E isoforms (epsilon 4 allele) vs. Total HDL-C alone and non-epsilon 4 alleles was evaluated on Prediction of coronary disease and vascular disease risk. HDL2-C and HDL3-C subfractions offer no advantage over total HDL-C across 19 studies for predicting coronary disease, while the apolipoprotein E epsilon 4 allele increases vascular disease risk.
Synapse has enriched 5 related papers. Consider them for comparative context: